which 12 presented the best evidence to answer the clinical question. The author, date, and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. It is concluded that a raised level of S-100b is a marker of poorer long-term outcome after both major and minor head injury.
Clinical Scenario
A 17 year old male presents to the Emergency Department after a road traffic accident. His GCS was 8 on arrival but an immediate CT scan showed no focal abnormality. His GCS returned to 14 after 4 hours. You are talking to his mother who is reassured that he does not need urgent neurosurgery, but she asks whether he will suffer any long term consequences from this injury. You tell her that it is difficult to predict. You have recently heard that S-100 protein measurement is available in your hospital for research purposes. You wonder whether S-100 could help predict his long term prognosis. Search outcome 200 papers were found of which 13 were found to be relevant. Two relevant papers described the same patient population. The remaining 12 papers are shown in the table.
Comments All studies were under 200 patients in size and most were under 100 patients. The studies find sensitivities from 27%-95% and specificities from 70% to 97%. The reasons for this great variation in findings may in large part be due to the small sample sizes. The specificities seem to perform better than the sensitivities and thus the finding of a high S-100 may indicate that your patient is at high risk of long term disability. The cut-points for a significant S-100 level differ between studies also and are generally much higher when applied to patients after a severe head injury. Most studies agree that S-100 levels must be taken within 6 hours of head injury.
c CLINICAL BOTTOM LINE A high S-100 level is a marker of poorer long term outcome following minor and major head injury. Abstract A short cut review was carried out to establish whether preinjury aspirin increases the risk of intracranial complications following head injury. 124 papers were found using the reported searches, of which three presented the best evidence to answer the clinical question. The author, date, and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses of these best papers are tabulated. It is concluded that aspirin may increase the risk of developing intracranial complications. More research is needed.
Clinical scenario
A 65 year old man on aspirin presents to the Emergency Department having fallen sustaining a minor head injury. You wonder whether he is at higher risk of intracranial bleeding due to aspirin. Comments There was conflicting evidence that prior chronic use of aspirin increases the risk of intracranial haemorrhage following minor head injury. However, there is some evidence to suggest that there is increased risk of chronic subdural haemorrhage. A well designed prospective cohort study with adequate sample size and follow up is needed to address such important and common problem. 
Three part question

